Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis

ClinicalTrials.gov ID: NCT02462083

Public ClinicalTrials.gov record NCT02462083. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 3:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Open Label Study to Evaluate the Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study is to evaluate the long-term safety of IDP-118 lotion.

Study identification

NCT ID
NCT02462083
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bausch Health Americas, Inc.
Industry
Enrollment
555 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 11, 2015 (Actual)
Primary completion
Jan 31, 2017 (Actual)
Completion
Apr 24, 2017 (Actual)
Last update posted
Jan 27, 2020

2015 – 2017

United States locations

U.S. sites
46
U.S. states
21
U.S. cities
41
Facility City State ZIP Site status
Valeant Site 6 Mobile Alabama 36603 —
Valeant Site 24 Beverly Hills California 90210 —
Valeant Site 32 Encinitas California 92023 —
Valeant Site 27 Encino California 91436 —
Valeant Site 33 Los Angeles California 90001 —
Valeant Site 43 Los Angeles California 90002 —
Valeant Site 45 Sacramento California 94203 —
Valeant Site 25 San Diego California 92093 —
Valeant Site 4 San Diego California 92093 —
Valeant Site 44 Santa Monica California 90401 —
Valeant Site 36 Santa Rosa California 95401 —
Valeant Site 10 Englewood Colorado 80113 —
Valeant Site 3 Boynton Beach Florida 33424 —
Valeant Site 28 Coral Gables Florida 33134 —
Valeant Site 1 Miami Florida 33101 —
Valeant Site 37 North Miami Beach Florida 33160 —
Valeant Site 13 Sanford Florida 32771 —
Valeant Site 41 Snellville Georgia 30039 —
Valeant Site 17 South Bend Indiana 46601 —
Valeant Site 12 Olathe Kansas 66051 —
Valeant Site 19 Louisville Kentucky 40201 —
Valeant Site 14 Louisville Kentucky 40205 —
Valeant Site 35 Clinton Township Michigan 48036 —
Valeant Site 34 Detroit Michigan 48201 —
Valeant Site 16 Warren Michigan 48088 —
Valeant Site 18 Fridley Minnesota 55421 —
Valeant Site 31 Omaha Nebraska 68022 —
Valeant Site 2 East Windsor New Jersey 08520 —
Valeant Site 29 New York New York 10001 —
Valeant Site 39 Rochester New York 14603 —
Valeant Site 5 Portland Oregon 97201 —
Valeant Site 11 Philadelphia Pennsylvania 19019 —
Valeant Site 30 Charleston South Carolina 29401 —
Valeant Site 15 Nashville Tennessee 37115 —
Valeant Site 9 Dallas Texas 75201 —
Valeant Site 40 Houston Texas 77001 —
Valeant Site 8 Houston Texas 77004 —
Valeant Site 46 Katy Texas 77449 —
Valeant Site 20 Pflugerville Texas 78660 —
Valeant Site 21 San Antonio Texas 78201 —
Valeant Site 7 San Antonio Texas 78202 —
Valeant Site 22 Webster Texas 77598 —
Valeant Site 38 Salt Lake City Utah 84101 —
Valeant Site 23 Lynchburg Virginia 24501 —
Valeant Site 26 Norfolk Virginia 23501 —
Valeant Site 42 Spokane Washington 99201 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02462083, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 27, 2020 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02462083 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →